New findings show promise for treatment of Graves' disease and other ocular disorders
Saturday, November 12, 2016 - 03:03
in Health & Medicine
Aryl hydrocarbon receptor ligands that block myofibroblast formation and collagen production in thyroid eye disease may be the key, according to a new report.